Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HI07
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 106 | 110 | PF00656 | 0.696 |
CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.616 |
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.561 |
CLV_NRD_NRD_1 | 289 | 291 | PF00675 | 0.506 |
CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.554 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.523 |
CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.531 |
CLV_PCSK_KEX2_1 | 289 | 291 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.623 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.500 |
CLV_PCSK_PC1ET2_1 | 191 | 193 | PF00082 | 0.531 |
CLV_PCSK_PC1ET2_1 | 97 | 99 | PF00082 | 0.623 |
CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 289 | 293 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 313 | 317 | PF00082 | 0.439 |
CLV_PCSK_SKI1_1 | 45 | 49 | PF00082 | 0.477 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.541 |
DEG_APCC_DBOX_1 | 302 | 310 | PF00400 | 0.484 |
DOC_CYCLIN_RxL_1 | 42 | 52 | PF00134 | 0.522 |
DOC_MAPK_gen_1 | 173 | 183 | PF00069 | 0.406 |
DOC_MAPK_gen_1 | 210 | 218 | PF00069 | 0.506 |
DOC_MAPK_gen_1 | 287 | 294 | PF00069 | 0.437 |
DOC_MAPK_MEF2A_6 | 210 | 219 | PF00069 | 0.504 |
DOC_MAPK_MEF2A_6 | 313 | 320 | PF00069 | 0.477 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.473 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.514 |
DOC_USP7_UBL2_3 | 191 | 195 | PF12436 | 0.565 |
DOC_USP7_UBL2_3 | 266 | 270 | PF12436 | 0.597 |
DOC_USP7_UBL2_3 | 88 | 92 | PF12436 | 0.593 |
DOC_WW_Pin1_4 | 37 | 42 | PF00397 | 0.520 |
LIG_14-3-3_CanoR_1 | 27 | 33 | PF00244 | 0.419 |
LIG_Actin_WH2_2 | 65 | 83 | PF00022 | 0.498 |
LIG_FHA_2 | 114 | 120 | PF00498 | 0.471 |
LIG_FHA_2 | 229 | 235 | PF00498 | 0.444 |
LIG_FHA_2 | 98 | 104 | PF00498 | 0.727 |
LIG_LIR_Gen_1 | 143 | 153 | PF02991 | 0.549 |
LIG_LIR_Gen_1 | 40 | 51 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 143 | 148 | PF02991 | 0.521 |
LIG_LIR_Nem_3 | 40 | 46 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 49 | 54 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 9 | 15 | PF02991 | 0.509 |
LIG_PDZ_Class_3 | 321 | 326 | PF00595 | 0.556 |
LIG_SH2_CRK | 145 | 149 | PF00017 | 0.513 |
LIG_SH2_STAP1 | 21 | 25 | PF00017 | 0.509 |
LIG_SH2_STAP1 | 43 | 47 | PF00017 | 0.408 |
LIG_SH2_STAP1 | 8 | 12 | PF00017 | 0.471 |
LIG_SH2_STAT3 | 8 | 11 | PF00017 | 0.561 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.481 |
LIG_SUMO_SIM_anti_2 | 213 | 221 | PF11976 | 0.497 |
LIG_SUMO_SIM_anti_2 | 304 | 311 | PF11976 | 0.391 |
LIG_SUMO_SIM_par_1 | 304 | 311 | PF11976 | 0.484 |
LIG_SUMO_SIM_par_1 | 46 | 52 | PF11976 | 0.475 |
LIG_TRAF2_1 | 116 | 119 | PF00917 | 0.560 |
LIG_TRAF2_1 | 125 | 128 | PF00917 | 0.475 |
LIG_TRAF2_1 | 204 | 207 | PF00917 | 0.398 |
LIG_TRAF2_1 | 232 | 235 | PF00917 | 0.543 |
LIG_TRAF2_1 | 239 | 242 | PF00917 | 0.505 |
LIG_UBA3_1 | 50 | 56 | PF00899 | 0.488 |
LIG_WRC_WIRS_1 | 7 | 12 | PF05994 | 0.569 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.613 |
MOD_CK2_1 | 201 | 207 | PF00069 | 0.443 |
MOD_CK2_1 | 228 | 234 | PF00069 | 0.441 |
MOD_CK2_1 | 243 | 249 | PF00069 | 0.387 |
MOD_CK2_1 | 266 | 272 | PF00069 | 0.589 |
MOD_CK2_1 | 305 | 311 | PF00069 | 0.448 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.481 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.752 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.494 |
MOD_GlcNHglycan | 260 | 263 | PF01048 | 0.521 |
MOD_GlcNHglycan | 321 | 324 | PF01048 | 0.413 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.393 |
MOD_GSK3_1 | 258 | 265 | PF00069 | 0.662 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.643 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.338 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.590 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.466 |
MOD_NEK2_1 | 46 | 51 | PF00069 | 0.527 |
MOD_PIKK_1 | 271 | 277 | PF00454 | 0.518 |
MOD_PKA_1 | 97 | 103 | PF00069 | 0.629 |
MOD_PKA_2 | 26 | 32 | PF00069 | 0.392 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.546 |
MOD_PKA_2 | 97 | 103 | PF00069 | 0.590 |
MOD_Plk_1 | 271 | 277 | PF00069 | 0.518 |
MOD_Plk_2-3 | 107 | 113 | PF00069 | 0.692 |
MOD_Plk_2-3 | 305 | 311 | PF00069 | 0.448 |
MOD_Plk_4 | 224 | 230 | PF00069 | 0.327 |
MOD_Plk_4 | 305 | 311 | PF00069 | 0.417 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.553 |
MOD_ProDKin_1 | 37 | 43 | PF00069 | 0.512 |
MOD_SUMO_for_1 | 211 | 214 | PF00179 | 0.412 |
MOD_SUMO_for_1 | 318 | 321 | PF00179 | 0.375 |
MOD_SUMO_rev_2 | 241 | 246 | PF00179 | 0.401 |
MOD_SUMO_rev_2 | 55 | 65 | PF00179 | 0.533 |
MOD_SUMO_rev_2 | 85 | 93 | PF00179 | 0.590 |
TRG_DiLeu_BaEn_1 | 213 | 218 | PF01217 | 0.471 |
TRG_DiLeu_BaLyEn_6 | 42 | 47 | PF01217 | 0.387 |
TRG_ENDOCYTIC_2 | 12 | 15 | PF00928 | 0.530 |
TRG_ENDOCYTIC_2 | 145 | 148 | PF00928 | 0.517 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.435 |
TRG_NLS_MonoExtN_4 | 188 | 194 | PF00514 | 0.620 |
TRG_Pf-PMV_PEXEL_1 | 245 | 249 | PF00026 | 0.434 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IM18 | Leptomonas seymouri | 70% | 100% |
A0A3Q8IFH1 | Leishmania donovani | 87% | 100% |
A0A422NIF5 | Trypanosoma rangeli | 40% | 100% |
A4I584 | Leishmania infantum | 87% | 100% |
E9B0I1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4Q7Q0 | Leishmania major | 87% | 100% |
V5AS86 | Trypanosoma cruzi | 36% | 99% |